Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Biogen looks to break free from SMA status quo after FDA agrees to high-dose version of Spinraza
By healthadmin
Since FDA approval of Spinraza nearly a decade ago, Biogen’s spinal muscular atrophy (SMA) treatment…
Navigating 2026 Pharma Trends: Challenges and Opportunities for Drug Development Leaders
By healthadmin
Pharmacologists, executives, and regulatory professionals face explosive growth in AI-powered drug discovery, biopharma manufacturing shifts, clinical pipelines, and FDA evolutions. Explore key trends and strategies for resilient growth.
Rocket chart measuring the trajectory of the new gene therapy drug Cresradi after receiving FDA approval
By healthadmin
With the green light from the FDA over the weekend, Rocket Pharmaceuticals is officially on…
Lilly’s position in the obesity market and broader GLP-1 space has remained largely unchallenged in…
Fierce Pharma Asia—Takeda Pharmaceutical’s $1.3 billion restructuring. GLP-1 sluice gate in India. Gilead acquires new Chinese company for $2.2 billion
By healthadmin
Takeda Pharmaceutical is embarking on a restructuring plan with the goal of saving about $1.3…
Family-owned Recordati, which is celebrating its 100th anniversary, is considering an acquisition offer from CVC…
With significant expansion works taking shape on both sides of the pond, specialist CDMO Hovione…
As questions swirl over ATTR competition, Alnylam plots Amvuttra’s path to market leadership
By healthadmin
Aruniram has big ambitions for Amvutra. However, despite the launch of explosive transthyretin amyloid cardiomyopathy…
Dr. Robert Malone, a physician and biochemist who became the prominent public face of the…
Corcept’s flagship drug recovers from FDA snub with different approval from Rifiorri for ovarian cancer
By healthadmin
Following a new U.S. green light for some ovarian cancer patients, Corcept Therapeutics has redeemed…